Kyverna Therapeutics is progressing toward filing its Biologics License Application (BLA) by Q4 2026 for a cell therapy targeting Stiff Person syndrome, a rare autoimmune disease with no current approved treatments. If successful, this would mark the first approved cell therapy for autoimmune diseases globally, positioning Kyverna as a pioneer in this field. The company highlighted its leadership in developing cell therapies for autoimmune conditions during the Morgan Stanley Global Healthcare Conference.
Kyverna Therapeutics, Inc. is the subject of this update. For readers following healthcare stocks, here is Pluang's market snapshot as of Sep 15, 2026 09:51 WIB: Among 91 priced US health-sector stocks, 73 rose and 18 fell today. Notable gainers include Twist Bioscience Corp (TWST) at USD 134.81 with a 5.97% increase, American Well Corp (AMWL) at USD 13.76 up 5.85%, and Summit Therapeutics Inc (SMMT) at USD 18.53 rising 5.58%.
A major crypto market deleveraging saw over 118,000 traders liquidated, with $815-$821 million wiped from leveraged positions, mainly longs. Bitcoin fell below $80,000 and Ether approached $2,350, signaling a market correction and reduced confidence ...
BioNTech and Bristol Myers Squibb reported promising Phase 2 results for pumitamig combined with docetaxel in advanced non-small cell lung cancer (NSCLC) patients who progressed after immunotherapy plus chemotherapy. The treatment showed a confirmed ...
US households' inflation expectations for the next year increased to 4.7% in October, the highest since May, while long-term expectations also rose. Consumer sentiment remained nearly unchanged, with mixed shifts in economic conditions and expectatio...
Tether has frozen 2,212,850.3 USDT across nine addresses connected to a security incident involving CoinDCX, following the detection of roughly 15.99 million USDT in unusual transfers. The investigation began after identifying these large suspicious ...
Andreessen Horowitz founder Shaw announced that 90% of the reverse-engineering work on all Pump.fun smart contracts is complete, with the remaining 10% expected to finish by October 25. Shaw emphasized the importance of making all contract code open ...
